CORDIS
EU research results

CORDIS

English EN

ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics

Project information

Grant agreement ID: 744110

  • Start date

    1 December 2016

  • End date

    31 March 2017

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

CELLPLY SRL

Italy

Objective

The advent of personalized cancer care demands for distributed diagnostic solutions to support clinical decisions and selection of the best therapeutic regimen. Supportive information can be obtained by analyzing the response of patient’s tissue to various treatment options. A specific opportunity arises in the field of cellular analysis, where the ex-vivo assessment of drug efficacy performed through drug response assays represents a powerful tool and, at the same time, a challenge due to the difficulty of maintaining in-vitro conditions that closely resemble in-vivo cell response.

CellPly developed a novel in-vitro diagnostic (IVD) product to define cell response to anti-cancer drug treatment through integrated drug response analyses. Oncosmart platform includes a smart consumable, integrating a hybrid polymer/flexible-PCB micro-technology, an analytical instrument and diagnostic software.

After patient’s tissue sampling, an automated process will carry out sample preparation, precise drug delivery and monitoring of cell response through time-lapse imaging. Cancer patients will benefit from more personalized cancer therapies, while the public health systems will reduce overall analysis and hospitalization costs and better allocate resources dedicated to cancer therapies.

The Phase 1 project will set up the a quality-certified manufacturing chain and plan the validation of the platform in clinical setting in the field of acute leukemia; regulatory pathways to comply with CE-IVD and to seek reimbursement will be assessed; the commercialization strategy and associated business model(s) will be elaborated.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

CELLPLY SRL

Address

Via Fondazza 53
40125 Bologna

Italy

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 50 000

Project information

Grant agreement ID: 744110

  • Start date

    1 December 2016

  • End date

    31 March 2017

Funded under:

H2020-EU.3.1.3.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

CELLPLY SRL

Italy

This project is featured in...